Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson’s Disease

Danshen has been widely used for the treatment of central nervous system diseases. We investigated the effect of dihydroisotanshinone I (DT), a compound extracted from Danshen, as well as the corresponding mechanisms in an in vitro-based 6-OHDA-induced Parkinson’s disease (PD) model. SH-SY5Y human n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:International Journal of Molecular Sciences
Asıl Yazarlar: Hui-Chen Su, Yuan-Ting Sun, Ming-Yu Yang, Ching-Yuan Wu, Cheng-Ming Hsu
Materyal Türü: Makale
Baskı/Yayın Bilgisi: MDPI AG 2023-07-01
Konular:
Idiopathic Parkinson’s disease
Danshen
Dihydroisotanshinone I
6-OHDA
<i>SIRT1</i>
<i>BMAL1</i>
Online Erişim:https://www.mdpi.com/1422-0067/24/13/11088
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Internet

https://www.mdpi.com/1422-0067/24/13/11088

Benzer Materyaller